+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

GERD prevalence in migraine patients and the implication for acute migraine treatment

GERD prevalence in migraine patients and the implication for acute migraine treatment

Journal of Headache and Pain 10(1): 35-43

The objective of this study is to estimate the prevalence of gastroesophageal reflux disease (GERD) and heartburn in migraine patients and examine their use of non-steroidal anti-inflammatory drugs (NSAIDs) or aspirin-containing medications when treating acute migraine attacks. Responses from a web-based survey of migraine patients were matched to the same patient's responses on a general health survey. A total of 1,832 migraineurs (92.0%) were successfully matched. A total of 403 migraineurs (22.0%) reported having diagnosed GERD, 212 (11.6%) reported diagnosed heartburn, and 290 (15.8%) reported reflux symptoms but were undiagnosed. The most common prescription drugs used to treat migraines were triptans. First-line NSAID/aspirin medication use was 10.0% among diagnosed GERD and heartburn patients, 17.8% among undiagnosed patients, and 11.8% among GERD/heartburn-free migraineurs. In conclusion, almost half of migraineurs reported physician-diagnosed GERD and heartburn or symptoms of these conditions. Use of NSAID medications for migraine is fairly common among diagnosed GERD patients and more so for those with undiagnosed GERD symptoms. Physicians should minimize prescribing NSAIDs or NSAID-containing acute migraine medications in this population.

(PDF emailed within 0-6 h: $19.90)

Accession: 053341019

Download citation: RISBibTeXText

PMID: 19009231

DOI: 10.1007/s10194-008-0083-1

Related references

Identifying patients who require a change in their current acute migraine treatment: the Migraine Assessment of Current Therapy (Migraine-ACT) questionnaire. Current Medical Research and Opinion 20(7): 1125-1135, 2004

Patterns of diagnosis and acute and preventive treatment for migraine in the United States: results from the American Migraine Prevalence and Prevention study. Headache 47(3): 355-363, 2007

Rizatriptan for treatment of acute migraine in patients taking topiramate for migraine prophylaxis. Headache 52(1): 57-67, 2012

Treatment of mild migraine with oral zolmitriptan 25 mg prevents progression to more severe migraine and reduces the impact on normal activities in patients with significant migraine-related disability. Neurology 58(7 Supplement 3): A291-A292, April 9, 2002

Subcutaneous sumatriptan in the acute treatment of migraine in patients using dihydroergotamine as prophylaxis. French Migraine Network Bordeaux-Lyon-Grenoble. Headache 33(8): 432-435, 1993

The one-year period prevalence of strict migraine, probable migraine , and the full spectrum of migraine within a health-plan population. Cephalalgia 23(7): 594, September, 2003

What do patients with migraine want from acute migraine treatment?. Headache 42(Supplement 1): S3-S9, January, 2002

Cost and predictors of lost productive time in chronic migraine and episodic migraine: results from the American Migraine Prevalence and Prevention (AMPP) Study. Value in Health 16(1): 31-38, 2013

Migraine prevalence and treatment patterns: The global Migraine and Zolmitriptan Evaluation survey. Headache 43(1): 19-26, January, 2003

Migraine prevalence, treatment and impact: the canadian women and migraine study. Canadian Journal of Neurological Sciences. le Journal Canadien des Sciences Neurologiques 37(5): 580-587, 2010

Anxiety and depression associated with migraine: influence on migraine subjects' disability and quality of life, and acute migraine management. Pain 118(3): 319-326, 2005

The Prevalence of Magnetic Resonance Imaging Hyperintensity in Migraine Patients and Its Association with Migraine Headache Characteristics and Cardiovascular Risk Factors. Oman Medical Journal 30(3): 203-207, 2015

Treatment of migraine attacks and migraine prophylaxis: recommendations of the German Migraine and Headache Society. Medizinische Monatsschrift für Pharmazeuten 21(2): 30-39, 1998

On the incidence of ocular diseases in severe migraine, common migraine and migraine states. Evaluation of the results obtained with oculistic treatment. Rivista Critica di Clinica Medica 68: Suppl 6:1022+-Suppl 6:1022+, 1968

Health care Resource Utilization and Migraine Disability Along the Migraine Continuum Among Patients Treated for Migraine. Headache: -, 2018